Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria

ANIK, İHSAN; ÇABUK, BURAK; Gokbel, Aykut; SELEK, ALEV; Cetinarslan, BERRİN; ANIK, YONCA; CEYLAN, SAVAŞ

doi:10.1016/j.wneu.2017.08.182

Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria

ANIK İ., ÇABUK B., Gokbel A., SELEK A., Cetinarslan B., ANIK Y., ...Daha Fazla

WORLD NEUROSURGERY, cilt.108, ss.278-290, 2017 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 108
Basım Tarihi: 2017
Doi Numarası: 10.1016/j.wneu.2017.08.182
Dergi Adı: WORLD NEUROSURGERY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.278-290
Anahtar Kelimeler: Adenoma, Cavernous sinus, Endoscope, Growth hormone, Transsphenoidal approach, SECRETING PITUITARY-ADENOMAS, GROWTH-HORMONE LEVELS, LONG-TERM REMISSION, SURGICAL-TREATMENT, CAVERNOUS SINUS, SURGERY, MANAGEMENT, CURE, PREDICTORS, PSEUDOCAPSULE
Kocaeli Üniversitesi Adresli: Evet

Özet

BACKGROUND: Transsphenoidal surgery is the first-choice treatment for acromegaly. Postoperative remission is an important predictor of outcome. Various factors have been described as markers of remission: preoperative mean growth hormone (GH) and insulin-like growth factor-1 levels, cavernous sinus invasion, tumor size, extrapseudocapsular resection, and experience of the surgeon.